Evidence has also shown that tumor exosomes are capable of delivering membrane-bound CD39 and CD73 proteins to regulatory T cells (Tregs), and potentially other immune cells, lacking the expression of either enzyme, to ultimately trigger production of adenosine (Schuler et al., 2014; Ludwig et al., 2017). Here, ENTPD1 is linked to neoplasm.